Hemp Future Week, Day 2: Cannabidiol (CBD)

Richard Rose

Your CannaCoach, Pioneer in the Hemp Industry for 24 Years. Consult the Consultant your Consultant consults.

Nothing has caused a revolution in hemp’s history like the development of the Cannabidiol (CBD) industry. Because of CBD, there has been more innovation and advances in hemp the last 2 years than in the previous 200.

CBD is beneficial to 100% of the human and pet population, has no “high,” is non-toxic, non-addictive, legal in the US and most countries, and is the most-predominant Cannabinoid in hemp (<0.3% THC Cannabis), wherein lies 95% of the CBD on the planet. Today, 99% of a hemp farmer’s return can be from CBD hemp, much higher than fiber, seed, or oil/protein. The economics of hemp have shifted that dramatically.

Cannabidiol (CBD) is not a Controlled Substance in the USA, due to a Ninth Circuit Court ruling in 2004. Those who say otherwise are either profoundly ignorant or have a hidden agenda.

CBD is preventative and/or therapeutic for many conditions, including alcoholism, ALS, Alzheimer’s, anxiety, apnea, arthritis, bone fractures, catalepsy, depression, diabetes, Dravets, DTs, eating disorders, epilepsy, free radicals, glaucoma, hangover, heart disease, Huntington’s, infection, infertility, inflammation, insomnia, liver damage, MRSA infection, nausea, neuro-degeneration, opiate addiction and withdrawal, pain, pancreatitis, Parkinson’s, psychosis, PTSD, RA, schizophrenia, stroke, TBI, tremors, and tumors. Cannabinoids generate new brain cells, and are useful in maintaining health and preventing disease.

A search of Google Patents for “Cannabidiol” returns 14,7000, the grand-daddy of which is the first CBD patent, in 1942, by the guy who discovered it, Roger Adams.

A search of Google Scholar for “Cannabidiol” returns 16,400. A search of PubMed for “Cannabidiol” returns 5,244.

Tomorrow in Hemp Future Week: Cannabisin B to fight cancer.

Hemp Future Week is a service of the American Hemp Association and the Medicinal Hemp Association.

0/5 (0 Reviews)